Golden Helix, Inc.

Scalability means every patient gets an answer, no matter how complex the case. As testing volumes grow, labs face increasing pressure to deliver rapid, reliable insights at scale. Golden Helix brings that data into action with VarSeq and VSWarehouse, enabling seamless interpretation within a scalable, compliant environment designed for variant interpretation and report generation. We enable your lab to process more samples, detect clinically relevant variants, and deliver confident results faster to patients because time is of the essence. See how Golden Helix can help your lab. Talk to our team today: https://lnkd.in/g58Mz4Hp #PrecisionMedicine #Genomics #ClinicalGenomics #NGS #Bioinformatics

Genome centers require infrastructure that can process whole genomes at scale while maintaining security and ensuring reliable, validated operations. VSWarehouse delivers a sovereign, enterprise-grade foundation for large-volume germline and somatic analysis. In this webcast, we’ll cover how VSWarehouse helps genome centers operate with confidence: • Pipelines optimized for germline singletons, duos, trios, and somatic tumor–normal workflows • Workspace architecture that partitions teams and projects with controlled collaboration • Cohort-level allele frequency generation from thousands of genomes • Enterprise security with SAML/LDAP SSO, full air-gap support, and a validated, penetration-tested design See how VSWarehouse provides the secure, scalable platform modern genome centers rely on to support population-scale sequencing programs and high-assurance clinical analysis. 📅 Register today! #Genomics #NGS #GenomeCenters #Bioinformatics #ClinicalGenomics #PopulationGenomics #GoldenHelix

In the fight against cancer, rapid, reliable insights to guide the most effective treatment decisions are key. Golden Helix eliminates hours of manual literature review by integrating the Genomenon Cancer Knowledgebase (CKB) within VarSeq, providing automated, expert-curated evidence that ensures every report reflects the latest oncology research. The results: faster turnaround, consistent reporting, and greater confidence in treatment-matching, helping providers deliver premier care when it matters most. Additionally, Golden Helix CancerKB offers clinical interpretations, further reducing the time required to go from FASTQ to a clinical report. See how automation advances oncology interpretation. Talk to our team today: https://lnkd.in/g58Mz4Hp #CancerGenomics #PrecisionOncology #Automation #GoldenHelix  

We have expanded Golden Helix CancerKB. Now, one of the most comprehensive clinical interpretation databases in precision oncology. Golden Helix CancerKB has undergone a significant expansion, delivering deeper clinical insight and broader coverage across the oncology landscape. The latest release includes: - More curated genes - Expanded diagnostic and prognostic summaries - New and updated therapeutic evidence With these additions, Golden Helix CancerKB has become one of the most robust and actionable knowledge bases available to support precision oncology workflows. Today, Golden Helix CancerKB contains: - 979 curated genes - 452 tumor-specific outcomes - 237 drugs - 17,749 treatments - 68,000+ clinical trials across 224 countries Every element is structured for seamless integration into VSClinical AMP. This high degree of curation and organization dramatically reduces manual review, improves interpretation consistency, and accelerates the delivery of report-ready insights to clinicians and patients. Our ongoing mission is clear: equip clinical laboratories with state-of-the-art tools that scale efficiently and reliably, enabling them to deliver high-quality, evidence-based results at speed and at scale. Learn more: https://lnkd.in/gRvAyPAS #PrecisionOncology #ClinicalGenomics #Bioinformatics #CancerResearch #GoldenHelix

As #ampath2025 comes to a close, we would like to thank everyone who stopped by Booth 543, attended our demos, and took the opportunity to speak with our experts. Your enthusiasm and questions made this event an incredible success. We look forward to continuing the conversation and advancing genomics together! #Genomics #GoldenHelix

Good morning from #ampath2025 in Boston! It’s our final day at the conference, so make sure to connect with the Golden Helix team at Booth 543. Join our last round of live demos, explore our complete NGS software suite, and grab your free t-shirt! Today’s Live Schedule • 9:20 AM – Streamlining Cancer Analysis with Oncogenicity Classifier and CancerKB • 10:00 AM – Whole Genome Analysis with Long Read Data • 12:00 PM – NGS Enterprise Capabilities: Automation, Integration, Warehousing • 12:40 PM – Enhancing Your Cancer Analysis with Genomenon CKB Learn more about our live demo schedule, here: https://bit.ly/4oUgyIF #GoldenHelix #Genomics

Good morning from #ampath2025 in Boston! We’re kicking off Day 2 at Booth 543 with more demos, more t-shirts, and more excitement! Stop by today to learn how Golden Helix is advancing precision medicine. Today’s Live Schedule • 9:25 AM – Streamlining Cancer Analysis with Oncogenicity Classifier and CancerKB • 12:00 PM – Whole Genome Analysis with Long Read Data • 12:45 PM – NGS Enterprise Capabilities: Automation, Integration, Warehousing • 3:00 PM – PGx: Pharmacogenomics Workflow • 3:30 PM – Enhancing Your Cancer Analysis with Genomenon CKB Learn more about our live demos, here: https://bit.ly/43OpWFx We'll see you soon! #GoldenHelix #Genomics

Good morning from #ampath2025 in Boston! We’re excited to kick off the first day of the conference. Visit Booth 543 to see how Golden Helix is shaping the future of genomic analysis. Today’s Live Demos • 12:00 PM – Streamlining Cancer Analysis with Oncogenicity Classifier and CancerKB • 12:45 PM – Whole Genome Analysis with Long Read Data • 2:20 PM – NGS Enterprise Capabilities: Automation, Integration, Warehousing • 3:35 PM – PGx: Pharmacogenomics Workflow • 4:15 PM – Enhancing Your Cancer Analysis with Genomenon CKB Join us for live demos, meet our experts, and explore the latest in genomics innovation. https://bit.ly/4oUgyIF #Genomics #GoldenHelix

We officially launched VarSeq 3 and VSWarehouse 3 also in DX mode, redefining scalability, automation, and clinical yield in genomic interpretation. This release delivers usage-based licensing that scales with lab throughput, cloud deployment through our Bring Your Own Cloud model, and enhanced automation that minimizes hands-on time and accelerates reporting. With comprehensive pipelines for both short- and long-read sequencing, labs can unify variant calling, annotation, and interpretation within a single secure, integrated framework. We also provided additional functionality to support our recently announced Genomenon Partnership. These advances enable clinical labs and hospitals to operate more efficiently, expand testing capacity, and deliver faster, more accurate insights that directly inform patient care. By combining scalability with precision, Golden Helix continues to make enterprise-grade genomics accessible for organizations of every size. You can learn more, here: https://lnkd.in/gWzrZDry #GoldenHelix #PrecisionMedicine #Genomics #Automation #ClinicalGenomics #NGS  

Join Golden Helix to explore the latest updates to CancerKB and VSClinical AMP, including expanded diagnostic and prognostic coverage for solid tumors and a more clinically aligned cancer ontology. Learn how to: • Apply the oncogenicity scoring algorithm in VarSeq. • Evaluate biomarkers with NCCN, WHO, and peer-reviewed evidence. • Streamline variant interpretation for consistent, clinically actionable insights. 📅 Register today! #Genomics #CancerDiagnostics #NGS #ClinicalGenomics #VariantInterpretation #GoldenHelix